• Pheromone Signaling and Neurodegeneration in C. elegans

  2026-10-02

  Peng et al. show that pheromone exposure during the L1 stage can reprogram neuronal development and accelerate neurodegeneration in adult C. elegans. The study identifies a synergistic ASK–ASI–AIA circuit that connects environmental chemical sensing with insulin-like signaling and reduced neuronal autophagy.

• Exemestane Workflows for Aromatase Research

  2026-10-01

  Build reproducible aromatase assays with Exemestane, from solvent preparation and time-dependent inhibition studies to breast cancer research models. Practical controls, concentration guidance, and troubleshooting help distinguish true estrogen biosynthesis inhibition from matrix, precipitation, or readout artifacts.

• Gemini QACs: Broad-Spectrum Biocidal Design

  2026-10-01

  A 2024 Bioorganic Chemistry study synthesized 16 octenidine-derived gemini quaternary ammonium compounds and identified leads with improved antibacterial, antifungal, and virucidal profiles. Its results show why antimicrobial potency, biofilm activity, cytotoxicity, solubility, and membrane-permeation predictions should be evaluated together rather than as isolated endpoints.

• p-Cresyl sulfate: Reliable Cell Assay Workflows

  2026-09-30

  This scenario-based guide explains how p-Cresyl sulfate, SKU A8895, can improve interpretation of viability, proliferation, wound-healing, and apoptosis assays. It covers preparation, albumin context, controls, vendor selection, and the limits of translating endothelial findings to hepatobiliary models.

• Ibrexafungerp Activity Against Resistant Candida auris

  2026-09-30

  Wiederhold and colleagues evaluated Ibrexafungerp, also known as MK 3118, against fluconazole-resistant Candida auris using broth microdilution and a neutropenic mouse model of invasive candidiasis. The study found consistent in vitro activity and meaningful reductions in mortality and kidney fungal burden when treatment began 24 hours after infection, supporting further investigation of oral glucan synthase inhibition for resistant C. auris.

• CB-5083: Practical p97 Inhibitor Workflows

  2026-09-29

  This scenario-driven guide explains how CB-5083, SKU B6032, can support reproducible cell viability, proliferation, and cytotoxicity studies through controlled dosing, solvent handling, and orthogonal endpoint selection. It connects biochemical p97 inhibition with protein homeostasis disruption while clearly separating established evidence from practical workflow recommendations.

• Mitoxantrone Targets the ERα DBD–LBD Interface

  2026-09-29

  Wang and colleagues identify mitoxantrone as a ligand for a previously underexplored interface between the estrogen receptor α DNA-binding and ligand-binding domains. Their data show that this interaction redirects ERα, promotes proteasomal degradation, and suppresses therapy-resistant ER signaling through a mechanism distinct from conventional hormone-pocket antagonism.

• Sulforaphane, Oxidative Stress, and NLRP3 in Colitis

  2026-09-28

  A 2024 mouse study shows that Sulforaphane reduces DSS-induced colitis alongside lower reactive oxygen species and suppressed NLRP3 inflammasome signaling. The work links redox imbalance to NLRP3–ASC–caspase-1 activation and provides a practical framework for studying inflammasome-driven intestinal inflammation.

• Sunitinib Workflows for RCC Resistance Research

  2026-09-28

  Turn Sunitinib’s multi-target RTK activity into a reproducible workflow for renal cell carcinoma, angiogenesis, and treatment-resistance studies. A recent TRIB3 study adds a ferroptosis-focused way to test sensitization—while practical controls help separate target inhibition from cell-death effects.

• Gepotidacin Mechanism at Staphylococcus aureus Gyrase

  2026-09-27

  This study shows that gepotidacin inhibits Staphylococcus aureus gyrase through a cleavage-complex mechanism distinct from the double-strand breaks associated with fluoroquinolones. Biochemical assays and two crystal structures link potent inhibition to single-strand DNA cleavage and reveal how one gepotidacin molecule occupies a pocket between the enzyme’s GyrA subunits.

• GSK 2837808A for LDHA and Lactate Research

  2026-09-26

  Use GSK 2837808A to test whether LDHA activity contributes to lactate production, glucose use, and cancer-cell metabolic phenotypes. This workflow distinguishes the compound’s established LDHA evidence from hypothesis-generating applications to the NAT1–ENO1–lactate pathway in colorectal cancer.

• Tolazoline for Airway and Islet Research

  2026-09-25

  Use Tolazoline to test whether α2-adrenergic signaling explains agonist-driven changes in cholinergic airway responses, while keeping its distinct islet and potassium-channel effects in view. A practical workflow pairs organ-bath controls with concentration-aware interpretation so receptor antagonism is not confused with direct bronchodilation or insulin secretion effects.

• Sphingosine-1-phosphate: Practical Assay Workflows

  2026-09-25

  Use Sphingosine-1-phosphate to probe receptor-dependent survival, inflammatory signaling, and apoptosis—not as a one-directional cell-survival switch. This workflow connects an acute intracerebral hemorrhage study to practical HT22 assays, with preparation, dose-finding, controls, and troubleshooting guidance.

• L. gasseri Protects the Barrier in DSS Colitis

  2026-09-24

  Qian and colleagues report that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis in mice while preserving intestinal barrier features, with E-cadherin and NR1I3 implicated in the protective response. The study combines probiotic intervention with intestinal E-cadherin loss-of-function and in vitro analyses, offering a mechanistic lead while leaving human efficacy and clinical translation unresolved.

• Genotyping Kit for Target Alleles: Workflow & Limits

  2026-09-24

  The Genotyping Kit for target alleles provides a single-tube route from insect, tissue, fish, or cell samples to PCR-ready genomic DNA. It is a sample-preparation tool—not a validated assay for the E-cadherin mouse model described in the cited colitis study.

8645 records 1/577 page Next 12345 下5页 Last page